Gene Expression Profiling in PBMCs as a Tool for Prediction of Anakinra Responsiveness in Rheumatoid Arthritis
NCT00213538
·
clinicaltrials.gov ↗
COMPLETED
Status
341
Enrollment
OTHER
Sponsor class
Conditions
Rheumatoid Arthritis
Interventions
DRUG:
Response to anakinra associated with methotrexate
Sponsor
University Hospital, Rouen